清晨好,您是今天最早来到科研通的研友!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您科研之路漫漫前行!

Cobalt picolinamide complexes as potential anti-cancer agents

化学 配体(生物化学) 取代基 硫氰酸盐 酰胺 立体化学 药物化学 无机化学 有机化学 生物化学 受体
作者
Laura Ghandhi
链接
摘要

This thesis details the synthesis of cobalt picolinamide complexes with potential chemotherapeutic applications. The anti-cancer, anti-bacterial and anti-fungal activity of these complexes was probed, with lead complexes undergoing further mechanistic investigations. Three series of cobalt picolinamide complex were investigated: cobalt(III) trispicolinamide, cobalt(II) bis-picolinamide and cobalt(III) mixed ligand complexes. Cobalt tris-picolinamide complexes consist of a cobalt(III) ion surrounded by three picolinamide ligands, bound through the pyridyl and amide nitrogen atoms. A minor isomer with different ligand coordination was formed under certain reaction conditions, provided that an electron donating group is present as a substituent on the picolinamide ligand. The formation of cobalt bis-picolinamide complexes was also only successful when electron donating groups were present on the picolinamide ligand. These complexes contain a cobalt(II) ion with two picolinamide ligands and two axial thiocyanate ligands. The cis/trans orientation of the thiocyanate ligands varies dependent upon the position of the picolinamide ligand substituent. Mixed ligand complexes consist of a cobalt(III) ion with two picolinamide ligands and one β-diketonate or ferrocenyl β-diketonate ligand. Complexes were screened for their anti-cancer potential against a number of cell lines. Cobalt bis-picolinamide and mixed ligand complexes were non-toxic. Some cobalt tris-picolinamide complexes displayed cytotoxicity, with the minor isomer displaying greater activity than the analogous major isomer. The two lead complexes were active against cancer cells and cancer stem cells. The mechanism of action is proposed to be inhibition of cell proliferation through interruption of the cell cycle at M phase. The lead complexes did not undergo hydrolysis, in contrast to the mixed ligand complexes containing the ferrocenyl β-diketonate ligand. The lead complexes could also adsorb onto an artificial biomembrane surface, unlike the inactive complexes, implying a correlation between cytotoxicity and cellular uptake. Additionally, cobalt bis-picolinamide complexes displayed antifungal activity against C. albicans, with the thiocyanate ligands essential for activity.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小公牛完成签到 ,获得积分10
1秒前
兴奋芸遥完成签到 ,获得积分10
1秒前
DHW1703701完成签到,获得积分10
12秒前
tfonda完成签到 ,获得积分10
16秒前
26秒前
风中秋天发布了新的文献求助10
35秒前
bellapp完成签到 ,获得积分10
35秒前
科研猫完成签到,获得积分10
46秒前
善学以致用应助肥皂剧采纳,获得10
48秒前
xc完成签到,获得积分10
53秒前
ttimmy完成签到,获得积分10
54秒前
吃的完成签到,获得积分10
59秒前
小文完成签到 ,获得积分10
1分钟前
kita完成签到 ,获得积分10
1分钟前
左柚发布了新的文献求助10
1分钟前
贪玩的网络完成签到 ,获得积分10
1分钟前
花誓lydia完成签到 ,获得积分10
1分钟前
junzzz完成签到 ,获得积分10
1分钟前
jingfortune完成签到 ,获得积分10
1分钟前
天天快乐应助sjfczyh采纳,获得10
1分钟前
hf完成签到,获得积分10
2分钟前
WenJun完成签到,获得积分10
2分钟前
研友_qZ6V1Z完成签到,获得积分10
2分钟前
大力的灵雁应助sjfczyh采纳,获得10
2分钟前
沸石完成签到 ,获得积分10
2分钟前
少年完成签到 ,获得积分10
2分钟前
2分钟前
2分钟前
lpp完成签到 ,获得积分10
2分钟前
wuyd90发布了新的文献求助10
2分钟前
hanliulaixi完成签到 ,获得积分10
2分钟前
波西米亚完成签到,获得积分10
2分钟前
likexin完成签到,获得积分10
2分钟前
九花青完成签到,获得积分10
2分钟前
俊逸吐司完成签到 ,获得积分10
2分钟前
drtianyunhong完成签到,获得积分10
2分钟前
我是老大应助mahuahua采纳,获得10
3分钟前
啊多啦完成签到 ,获得积分10
3分钟前
jh完成签到 ,获得积分10
3分钟前
GMEd1son完成签到,获得积分10
3分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Inorganic Chemistry Eighth Edition 1200
Free parameter models in liquid scintillation counting 1000
Standards for Molecular Testing for Red Cell, Platelet, and Neutrophil Antigens, 7th edition 1000
The Organic Chemistry of Biological Pathways Second Edition 800
The Psychological Quest for Meaning 800
Signals, Systems, and Signal Processing 610
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 工程类 有机化学 化学工程 生物化学 计算机科学 物理 内科学 复合材料 催化作用 物理化学 光电子学 电极 细胞生物学 基因 无机化学
热门帖子
关注 科研通微信公众号,转发送积分 6314204
求助须知:如何正确求助?哪些是违规求助? 8130426
关于积分的说明 17037195
捐赠科研通 5370057
什么是DOI,文献DOI怎么找? 2851151
邀请新用户注册赠送积分活动 1828940
关于科研通互助平台的介绍 1681102